Over the past 50 years, great strides have been made in elucidating the role of atherogenic lipoproteins in atherosclerosis. A vast amount of evidence now illustrates that LDL cholesterol (LDL-C) plays a pivotal role in elevating cardiovascular risk and that lowering levels are beneficial. At the Amgen sponsored breakfast symposium at the CSANZ ASM 2019 ...
Why it’s crucial to identify and treat all patients with elevated LDL cholesterol
1 Oct 2019
Sponsored by Amgen Australia Pty Ltd